Inherited retinal diseases: therapeutics, clinical trials and end points—a review
M Georgiou, K Fujinami… - Clinical & Experimental …, 2021 - Wiley Online Library
Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous group of
disorders characterised by photoreceptor degeneration or dysfunction. These disorders …
disorders characterised by photoreceptor degeneration or dysfunction. These disorders …
[HTML][HTML] Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives
AV Garafalo, AV Cideciyan, E Héon, R Sheplock… - Progress in retinal and …, 2020 - Elsevier
Due to improved phenotyping and genetic characterization, the field of 'incurable'and
'blinding'inherited retinal diseases (IRDs) has moved substantially forward. Decades of …
'blinding'inherited retinal diseases (IRDs) has moved substantially forward. Decades of …
Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
J Cehajic-Kapetanovic, K Xue… - Nature medicine, 2020 - nature.com
Retinal gene therapy has shown great promise in treating retinitis pigmentosa (RP), a
primary photoreceptor degeneration that leads to severe sight loss in young people. In the …
primary photoreceptor degeneration that leads to severe sight loss in young people. In the …
[HTML][HTML] The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies
X-linked retinopathies represent a significant proportion of monogenic retinal disease. They
include progressive and stationary conditions, with and without syndromic features. Many …
include progressive and stationary conditions, with and without syndromic features. Many …
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod …
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age
population and children. The scope of this review is to familiarise clinicians and scientists …
population and children. The scope of this review is to familiarise clinicians and scientists …
Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa
MD Fischer, ME McClements, CMF de la Camara… - Molecular Therapy, 2017 - cell.com
X-linked retinitis pigmentosa (XLRP) is generally a severe form of retinitis pigmentosa, a
neurodegenerative, blinding disorder of the retina. 70% of XLRP cases are due to mutations …
neurodegenerative, blinding disorder of the retina. 70% of XLRP cases are due to mutations …
Opportunities and challenges for molecular understanding of ciliopathies–the 100,000 genomes project
G Wheway… - Frontiers in …, 2019 - frontiersin.org
Cilia are highly specialized cellular organelles that serve multiple functions in human
development and health. Their central importance in the body is demonstrated by the …
development and health. Their central importance in the body is demonstrated by the …
NLRP3 attenuates intraocular inflammation by inhibiting AIM2‐mediated pyroptosis through the phosphorylated salt‐inducible kinase 1/sterol regulatory element …
J Meng, N Li, X Liu, S Qiao, Q Zhou, J Tan… - Arthritis & …, 2023 - Wiley Online Library
Objective The NLRP3 inflammasome has been shown to be involved in the development of
uveitis, but the exact mechanism remains elusive. This study was undertaken to explore the …
uveitis, but the exact mechanism remains elusive. This study was undertaken to explore the …
Loss of RPGR glutamylation underlies the pathogenic mechanism of retinal dystrophy caused by TTLL5 mutations
X Sun, JH Park, J Gumerson, Z Wu… - Proceedings of the …, 2016 - National Acad Sciences
Mutations in the X-linked retinitis pigmentosa GTPase regulator (RPGR) gene are a major
cause of retinitis pigmentosa, a blinding retinal disease resulting from photoreceptor …
cause of retinitis pigmentosa, a blinding retinal disease resulting from photoreceptor …
rAAV-compatible MiniPromoters for restricted expression in the brain and eye
CN De Leeuw, AJ Korecki, GE Berry, JW Hickmott… - Molecular brain, 2016 - Springer
Background Small promoters that recapitulate endogenous gene expression patterns are
important for basic, preclinical, and now clinical research. Recently, there has been a …
important for basic, preclinical, and now clinical research. Recently, there has been a …